3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
14
Carcinoma, Non-Small-Cell Lung
9
Ovarian Neoplasms
8
Urinary Bladder Neoplasms
6
Fallopian Tube Neoplasms
6
Carcinoma, Hepatocellular
6
Colorectal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Melanoma
4
Carcinoma, Renal Cell
4
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Mouth Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Glioblastoma
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Urethral Neoplasms
2
Ureteral Neoplasms
2
Thyroid Neoplasms
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Oropharyngeal Neoplasms
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Interventions
Nivolumab
2
trametinib
1
selpercatinib
1
lenvatinib
1
fludarabine
1
dabrafenib
1
cemiplimab
1
aldesleukin
1
Radiotherapy, Intensity-Modulated
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Carcinoma, Anaplastic
×
Disulfides
×
90 days
×
Clear all
No trials found.